Chunrui Li

19PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersClinimetricsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 26, 2026
Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.

|Jun 23, 2026
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

|Mar 27, 2026
Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T Therapy.

Chen Zhao, Lei Qiu, Ning An

|Mar 26, 2026
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study.

Ning An, Di Wang, Peiling Zhang

|Oct 24, 2025
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL.

Xiaoying Zhang, Jue Wang, Na Wang

|Jun 03, 2025
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.

Sikander Ailawadhi, Ivan Špička, Andrew Spencer

Pageof 4

Frequent Collaborators

6 joint publications

Liang Huang

3 joint publications

Wen Wang

3 joint publications

Jianfeng Zhou

2 joint publications

Jue Wang